Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on November 24th, 2021 | 13:05 CET
Gazprom, Tembo Gold, Nvidia - Inflation and rare goods
Inflation has jumped not only in the USA but also in Germany. With an inflation rate of 4.5% in October, we now have the highest value in Germany in almost three decades. One driver of monetary devaluation is the cost of energy, which has become significantly more expensive, especially in the past year. While the oil price was still in negative territory at the beginning of the pandemic, it was recently quoted above USD 80. The chip shortage can be observed in the automotive industry, but graphics cards are also rare and are traded at a significant premium to the recommended retail price. Graphics cards are used for mining cryptocurrencies. It seems that bitcoin is increasingly becoming a value protection asset and competes with gold, the number one inflation protection.
Read
Commented by Armin Schulz on November 22nd, 2021 | 11:45 CET
Alibaba, Troilus Gold, Secunet Security Networks - New highs after setbacks?
Inflation is growing. There are supply chain problems, and also, the Corona numbers are rising in many countries. Surprisingly, almost all indices are trading near their highs. Of course, this is not true for some stocks, as there are always companies that fail to meet analysts' lofty expectations. In these cases, the price of the shares often fall. Another possibility is capital increases, which dilute investors' shares and thus cause a setback. Such opportunities are sometimes favorable to find an entry into a stock. In this regard, we analyze three companies today.
Read
Commented by Armin Schulz on November 19th, 2021 | 11:21 CET
Valneva, Cardiol Therapeutics, Novavax - Is the Corona emergency brake coming?
Today, the Robert Koch Institute reported 65,371 new infections, a new sad record. In Berlin, politicians are currently discussing how to proceed. Abolishing the free tests to increase the pressure on the unvaccinated has proven wrong in retrospect. The fact that booster vaccinations might be necessary was also not considered when the vaccination centers were closed. Now the first state is discussing the next lockdown. If the numbers continue to rise, the emergency brake will be pulled in Berlin sooner or later. In parts of Austria, it is already a reality. We take a look at three possible winners of a lockdown.
Read
Commented by Armin Schulz on November 17th, 2021 | 10:21 CET
TeamViewer, Aspermont, TUI - Three turnaround candidates in check
If you still want to find favorable shares in today's market, you have to look for turnaround candidates. These companies are basically in a particular situation, which often leads to poor business figures. In some cases, business activities are questioned, and a restructuring concept is developed to guide the Company out of the crisis. If this succeeds, high profits beckon to investors. However, one should not reach for falling knives too early. Today, we analyze three companies where the turnaround could be imminent.
Read
Commented by Armin Schulz on November 15th, 2021 | 11:31 CET
Infineon, Almonty Industries, K+S - Profiting from supply bottlenecks
It is not only the printing presses of the central banks that are causing inflation in the USA and Europe but also the supply bottlenecks in more and more sectors. The chip shortage has been known for some time, but there is already a shortage of raw materials such as steel, cement, copper, nickel, tungsten, and even fertilizers. The infrastructure package of the USA, which was passed a good week ago, contributes its part to this. In addition to the existing packages, another USD 550 billion package will further fuel demand in the commodities mentioned above. The beneficiaries will be the producers, three of which we take a closer look at today.
Read
Commented by Armin Schulz on November 12th, 2021 | 10:29 CET
Barrick Gold, Barsele Minerals, Newmont - Inflation protection for own assets
Inflation in the USA continues to rise. While in September it was already 5.4%, in October it reached 6.2%. This figure surprised even the pessimistic experts, who had assumed only 5.8%. The reasons given are energy prices and supply bottlenecks. In Germany, the situation is not much better. The inflation rate was most recently 4.5%. It is said that this inflation is only temporarily so high. But already since Mr. Draghi, it should be clear that the central banks welcome inflation because, in this way, one can let the printing press run longer. As an investor, you should protect your money. Demand for physical gold rose 18% in the third quarter. Alternatively, one can invest in gold companies, of which we analyze three.
Read
Commented by Armin Schulz on November 10th, 2021 | 12:53 CET
AMD, BrainChip, Nvidia - Profiting from Artificial Intelligence
The first research into artificial intelligence (AI) began in the 1950s, but it was quite a while before any real progress was seen. This was largely due to ever-faster processors that could process even the largest amounts of data much faster than the old mainframes. We can see what artificial intelligence is capable of in digital assistants like Siri, Alexa, or translation programs like Google. In the coming years, artificial intelligence will penetrate more and more areas and automate many processes that were unthinkable until recently. Today we analyze three companies that produce hardware for the AI sector.
Read
Commented by Armin Schulz on November 8th, 2021 | 10:25 CET
Varta, Manganese X Energy, BYD - Batteries are becoming more and more important
Batteries have been around for a long time, but the old lead-acid batteries are gradually being replaced by lithium-ion batteries, which can be recharged much more often and thus have a much longer life. All these batteries require raw materials such as cobalt, nickel or manganese. The mining of cobalt does not have the best reputation, so Tesla has already reduced the proportion of cobalt. The alternative is called manganese, and this raw material is also absolutely needed by the steel industry. With the electrification of cars, demand will increase. The battle for the longest-lasting battery, greatest range and fastest charging capability is in full swing. We, therefore, take a look at three companies involved in batteries.
Read
Commented by Armin Schulz on November 5th, 2021 | 10:46 CET
JinkoSolar, Silver Viper, Daimler - Silver is versatile and has potential
Silver is versatile. In the medical field, the property of silver helps to have an antibacterial effect. The same applies to water pipes. In industry, silver is used in televisions, microwaves, monitors, etc. Silver also finds its applications everywhere in the energy sector, from wind power to solar panels to batteries and accumulators. Thus, silver will also be important for the automotive industry in the future, as it relies on electric cars, which require rechargeable batteries. It is assumed that the industry will need three times more silver in the future than it does now. Today we take a look at three companies involved in silver.
Read
Commented by Armin Schulz on November 3rd, 2021 | 11:03 CET
MorphoSys, Defence Therapeutics, Formycon - Biotech and pharma offer potential for the portfolio
The pharmaceutical industry alone has annual sales of over EUR 1,000 billion worldwide and helps people overcome their illnesses. Since the Corona pandemic, biotech and pharma companies are even more in the spotlight. If a company manages to develop a blockbuster, big profits also beckon to shareholders. BioNTech is currently a prime example of this, even if the share has consolidated in the meantime. Where there are high profits, there is also a higher risk. The road to the development and approval of a drug is long, and failure is also possible. As people are getting older and diseases are rising, it makes sense to invest in these areas. Today we analyze three potential candidates.
Read